Fiasp

entity.node.canonical

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/screen-shot-2017-10-02-at-5.48.07-pm.png?itok=KCf5yOmy

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/screen-shot-2017-10-02-at-5.48.07-pm.png?itok=-XtWkZ_7

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/screen-shot-2017-10-02-at-5.48.07-pm.png?itok=Nrca4GHU

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/screen-shot-2017-10-02-at-5.48.07-pm.png?itok=z_s0ET1Y

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/screen-shot-2017-10-02-at-5.48.07-pm.png?itok=r3cUZ7I7

<p>Faster version of Novo Nordisk’s NovoLog approved in the US for type 1 and type 2 diabetes, launch expected as early as end of 2017</p>
